Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.
Frizziero, Melissa Lamarca, Angela Kordatou, Zoe Barriuso, Jorge Nuttall, Christina McNamara, Mairéad G Hubner, Richard A Mansoor, Was Manoharan, Prakash Valle, Juan W
Frizziero, Melissa
Lamarca, Angela
Kordatou, Zoe
Barriuso, Jorge
Nuttall, Christina
McNamara, Mairéad G
Hubner, Richard A
Mansoor, Was
Manoharan, Prakash
Valle, Juan W
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence. 2018, 106: 77-77 Neuroendocrinology